Fumagillin: an anti-infective as a parent molecule for novel angiogenesis inhibitors. (Q34659698)

3 August 2017

1 reference

title

Fumagillin: an anti-infective as a parent molecule for novel angiogenesis inhibitors. (English)

1 reference

3 August 2017

main subject

angiogenesis inhibitor

1 reference

Benjamin Lefkove

1

1 reference

3 August 2017

Baskaran Govindarajan

series ordinal

2

1 reference

3 August 2017

Jack L Arbiser

series ordinal

3

1 reference

3 August 2017

publication date

1 August 2007

1 reference

Expert Review of Anti-infective Therapy

3 August 2017

published in

1 reference

3 August 2017

volume

5

1 reference

3 August 2017

issue

4

1 reference

3 August 2017

page(s)

573-579

1 reference

Molecular recognition of angiogenesis inhibitors fumagillin and ovalicin by methionine aminopeptidase 2

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.573

Imatinib-induced regression of AIDS-related Kaposi's sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.573

Activity of subcutaneous interleukin-12 in AIDS-related Kaposi sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.573

Inhibition of vessel permeability by TNP-470 and its polymer conjugate, caplostatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.573

Fumagillin suppresses HIV-1 infection of macrophages through the inhibition of Vpr activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.573

A novel mechanism of action of the fumagillin analog, TNP-470, in the B16F10 murine melanoma cell line.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.573

Structure of human methionine aminopeptidase-2 complexed with fumagillin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.573

Trial of oral fumagillin for the treatment of intestinal microsporidiosis in patients with HIV infection. ANRS 054 Study Group. Agence Nationale de Recherche sur le SIDA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.573

Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.573

Antimicrosporidial activities of fumagillin, TNP-470, ovalicin, and ovalicin derivatives in vitro and in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.573

New anti-angiogenesis agents: review of the clinical experience with carboxyamido-triazole (CAI), thalidomide, TNP-470 and interleukin-12

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.573

Fumagillin treatment of intestinal microsporidiosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.573

Disseminated microsporidiosis in a renal transplant recipient

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.573

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.573

TNP-470 fails to block the onset of angiogenesis and early tumor establishment in an intravital minimal disease model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.573

Pharmacologic blockade of angiopoietin-2 is efficacious against model hemangiomas in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.573

21 January 2018

Identifiers

DOI

10.1586/14787210.5.4.573

1 reference

3 August 2017

1 reference